Archive for Hemispherx

FDA Denial of Ampligen Exposes Out of Touch Agency; Hemispherx to Appeal

Hemispherx released a statement on Monday indicating the FDA had denied their application of Ampligen to treat Chronic Fatigue Syndrome (ME/CFS) because of lack of   'substantial' proof of efficacy and (rather ominously) because  they did not have enough data to assess safety concerns. The Read more [...]